Literature DB >> 24837863

School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.

Clément Chollat1, Maya Enser2, Estelle Houivet3, Delphine Provost2, Jacques Bénichou3, Loïc Marpeau4, Stéphane Marret5.   

Abstract

In a French randomized trial, children at school-age demonstrated no evidence of harm from fetal exposure to MgSO4 before very preterm birth. Motor dysfunction/death, qualitative behavioral disorders, cognitive difficulties, school grade repetition, and education services were decreased in the children exposed to MgSO4, although the differences were not significant.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24837863     DOI： 10.1016/j.jpeds.2014.04.007

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  18 in total

Review 1.  Cognitive outcomes of prenatal antiepileptic drug exposure.

Authors:  Katherine Inoyama; Kimford J Meador
Journal:  Epilepsy Res       Date:  2015-05-02       Impact factor: 3.045

Review 2.  Interleukin-1: an important target for perinatal neuroprotection?

Authors:  Sharmony B Kelly; Elys Green; Rod W Hunt; Claudia A Nold-Petry; Alistair J Gunn; Marcel F Nold; Robert Galinsky
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

3.  Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants.

Authors:  Betsy Ostrander; Tyler Bardsley; Ernest Kent Korgenski; Tom Greene; Joshua L Bonkowsky
Journal:  Pediatr Neurol       Date:  2016-03-03       Impact factor: 3.372

Review 4.  The fetus at the tipping point: modifying the outcome of fetal asphyxia.

Authors:  Simerdeep K Dhillon; Christopher A Lear; Robert Galinsky; Guido Wassink; Joanne O Davidson; Sandra Juul; Nicola J Robertson; Alistair J Gunn; Laura Bennet
Journal:  J Physiol       Date:  2018-06-21       Impact factor: 5.182

5.  Magnesium sulfate reduces EEG activity but is not neuroprotective after asphyxia in preterm fetal sheep.

Authors:  Robert Galinsky; Vittoria Draghi; Guido Wassink; Joanne O Davidson; Paul P Drury; Christopher A Lear; Alistair J Gunn; Laura Bennet
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 6.  Preventing Brain Injury in the Preterm Infant-Current Controversies and Potential Therapies.

Authors:  Nathanael Yates; Alistair J Gunn; Laura Bennet; Simerdeep K Dhillon; Joanne O Davidson
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

7.  Tract shape modeling detects changes associated with preterm birth and neuroprotective treatment effects.

Authors:  Devasuda Anblagan; Mark E Bastin; Sarah Sparrow; Chinthika Piyasena; Rozalia Pataky; Emma J Moore; Ahmed Serag; Alastair Graham Wilkinson; Jonathan D Clayden; Scott I Semple; James P Boardman
Journal:  Neuroimage Clin       Date:  2015-03-28       Impact factor: 4.881

8.  Comparison in outcomes at two-years of age of very preterm infants born in 2000, 2005 and 2010.

Authors:  Lénaïg Abily-Donval; Gaëlle Pinto-Cardoso; Alexandra Chadie; Anne-Marie Guerrot; Stéphanie Torre; Stéphane Rondeau; Stéphane Marret
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 9.  Perinatal neuroprotection update.

Authors:  Angie C Jelin; Kirsten Salmeen; Dawn Gano; Irina Burd; Mari-Paule Thiet
Journal:  F1000Res       Date:  2016-08-09

Review 10.  Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines.

Authors:  Xianling Zeng; Yan Xue; Quan Tian; Rong Sun; Ruifang An
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.